Manhattan Scientifics, Inc. (MHTX)
0.0000
0.00 (0.00%)
USD |
OTCM |
Sep 02, 16:00
Manhattan Scientifics Research and Development Expense (TTM)
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.01M |
| March 31, 2024 | 0.013M |
| December 31, 2023 | 0.01M |
| September 30, 2023 | 0.012M |
| June 30, 2023 | 0.011M |
| March 31, 2023 | 0.008M |
| December 31, 2022 | 0.011M |
| September 30, 2022 | 0.009M |
| June 30, 2022 | 0.01M |
| March 31, 2022 | 0.01M |
| December 31, 2021 | 0.01M |
| September 30, 2021 | 0.011M |
| June 30, 2021 | 0.011M |
| March 31, 2021 | 0.011M |
| December 31, 2020 | 0.011M |
| September 30, 2020 | 0.01M |
| June 30, 2020 | 0.01M |
| March 31, 2020 | 0.01M |
| December 31, 2019 | 0.008M |
| September 30, 2019 | 0.006M |
| June 30, 2019 | 0.003M |
| March 31, 2019 | 0.022M |
| December 31, 2018 | 0.052M |
| September 30, 2018 | 0.072M |
| June 30, 2018 | 0.072M |
| Date | Value |
|---|---|
| March 31, 2018 | 0.097M |
| December 31, 2017 | 0.89M |
| September 30, 2017 | 1.626M |
| June 30, 2017 | 2.215M |
| March 31, 2017 | 3.197M |
| December 31, 2016 | 3.335M |
| September 30, 2016 | 3.579M |
| June 30, 2016 | 3.747M |
| March 31, 2016 | 3.345M |
| December 31, 2015 | 2.937M |
| September 30, 2015 | 2.385M |
| June 30, 2015 | 2.17M |
| March 31, 2015 | 2.019M |
| December 31, 2014 | 1.861M |
| September 30, 2014 | 2.318M |
| June 30, 2014 | 1.776M |
| March 31, 2014 | 1.333M |
| December 31, 2013 | 0.96M |
| September 30, 2013 | 0.329M |
| June 30, 2013 | 0.329M |
| March 31, 2013 | 0.297M |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Tenax Therapeutics, Inc. | 45.26M |
| Exicure, Inc. | 2.029M |
| Century Therapeutics, Inc. | 66.62M |
| Absci Corp. | 86.49M |
| Celularity, Inc. | 9.222M |